Page last updated: 2024-10-26

valproic acid and Cachexia

valproic acid has been researched along with Cachexia in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Cachexia: General ill health, malnutrition, and weight loss, usually associated with chronic disease.

Research Excerpts

ExcerptRelevanceReference
"Treatment with valproic acid decreases muscle myostatin levels and enhances both follistatin expression and the inactivating phosphorylation of GSK-3beta, while these parameters are not affected by trichostatin-A."1.35Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. ( Baccino, FM; Bonelli, G; Bonetto, A; Costelli, P; Minero, VG; Penna, F; Reffo, P, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, R1
Zhang, S1
Hu, W1
Lu, X1
Lou, N1
Yang, Z1
Chen, S1
Zhang, X1
Yang, H1
Bonetto, A1
Penna, F1
Minero, VG1
Reffo, P1
Bonelli, G1
Baccino, FM1
Costelli, P1

Other Studies

2 other studies available for valproic acid and Cachexia

ArticleYear
Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    American journal of physiology. Cell physiology, 2016, 07-01, Volume: 311, Issue:1

    Topics: Adenocarcinoma; Animals; Binding Sites; Cachexia; Carcinoma, Lewis Lung; CCAAT-Enhancer-Binding Prot

2016
Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice.
    Current cancer drug targets, 2009, Volume: 9, Issue:5

    Topics: Animals; Cachexia; Colonic Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme I

2009